Remternetug (LY3372993) is a humanised monoclonal antibody targeting N3pG-Abeta, recognising pyroglutamated Abeta within amyloid plaques, applicable for Alzheimers disease.
Purity:
98.70%
CAS Number:
[2571940-41-3]
Target:
Beta Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted